Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 SUPPLY CHAIN ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 BUSINESS STRATEGY EXCELLENCE
4.6 CASE STUDIES
4.7 STRENGTH OF PRODUCT PORTFOLIO
4.8 TECHNOLOGICAL TRENDS
4.9 PRICING ANALYSIS
5 INDUSTRY INSIGHTS
6 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 GROWING PREVALENCE OF CANCER, CHRONIC INFLAMMATION, AUTOIMMUNE DISEASE, LYME DISEASE, AND OTHER CHRONIC DEGENERATIVE DISEASES
7.1.2 INCREASING INVESTMENTS IN PHARMACEUTICAL R&D AND LIFE SCIENCES RESEARCH
7.1.3 AVAILABILITY OF VARIOUS EXOSOME ISOLATION AND PURIFICATION TECHNIQUES AND PROGRESSING THERAPEUTIC VALUE OF EXOSOME
7.2 RESTRAINTS
7.2.1 LACK OF GOLD STANDARD PROTOCOLS FOR THE DEVELOPMENT AND PRODUCTION OF EXOSOMES
7.2.2 THE SHORTAGE OF SKILLED PROFESSIONALS REQUIRED FOR THE ISOLATION OF EXOSOME
7.3 OPPORTUNITIES
7.3.1 RISING DEMAND FOR SPECIALIZED TESTING SERVICES AMONG END USERS.
7.3.2 INCREASING ADVANCEMENT IN EXOSOME TECHNOLOGY
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 SIDE EFFECTS ASSOCIATED WITH EXOSOME RESEARCH PRODUCTS
7.4.2 LATE APPROVAL ASSOCIATED WITH PRODUCT LAUNCHES
8 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 CONSUMABLES
8.2.1 KITS AND REAGENTS
8.2.1.1 EXOSOME BIOMARKER KITS
8.2.1.2 EXOSOME ISOLATION KITS
8.2.1.3 EXOSOME PURIFICATION KITS
8.2.1.4 EXOSOME QUANTITATIVE KITS
8.2.1.5 EXOSOME DETECTION KITS
8.2.1.6 OTHERS
8.2.2 EXOSOME STANDARDS
8.2.3 EXOSOME ANTIBODIES
8.2.4 CELL LINES
8.2.5 IMMUNOPLATES
8.2.6 IMMUNOBEADS
8.2.7 BIOFLUIDS
8.2.8 OTHERS
8.3 INSTRUMENTS
8.3.1 BENCHTOP
8.3.2 STANDALONE
9 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION
9.1 OVERVIEW
9.2 CANCER
9.2.1 LUNG CANCER
9.2.2 BREAST CANCER
9.2.3 COLORECTAL CANCER
9.2.4 PROSTATE CANCER
9.2.5 OTHER CANCER
9.3 NON-CANCER
9.3.1 CARDIOVASCULAR DISEASE
9.3.2 NEURODEGENERATIVE DISEASE
9.3.3 INFECTIOUS DISEASE
9.3.4 OTHERS
10 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION
10.1 OVERVIEW
10.2 THERAPEUTICS
10.3 CONSUMABLES
10.4 INSTRUMENTS
10.5 DIAGNOSIS
10.6 CONSUMABLES
10.7 INSTRUMENTS
11 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER
11.1 OVERVIEW
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY
11.3 CONSUMABLES
11.4 INSTRUMENTS
11.5 RESEARCH CENTRES
11.6 CONSUMABLES
11.7 INSTRUMENTS
11.8 ACADEMIC INSTITUTES
11.9 CONSUMABLES
11.1 INSTRUMENTS
11.11 CLINICAL TESTING LABORATORY
11.12 CONSUMABLES
11.13 INSTRUMENTS
11.14 HOSPITALS
11.15 CONSUMABLES
11.16 INSTRUMENTS
11.17 OTHERS
12 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 THIRD PARTY DISTRIBUTORS
12.3 DIRECT SALES
12.4 ONLINE
13 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 THERMO FISHER SCIENTIFIC INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 EXODX (ACQUIRED BY BIO-TECHNE)
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 MILTENYI BIOTEC
16.3.1 COMPANY SNAPSHOT
16.3.2 COMPANY SHARE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 LUMINEX CORPORATION
16.4.1 COMPANY SNAPSHOT
16.4.2 PRODUCT PORTFOLIO
16.4.3 RECENT DEVELOPMENT
16.5 HOLOGIC, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 AETHLON MEDICAL, INC. (2022)
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 AGILENT TECHNOLOGIES, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 AMSBI0
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 AUDUBON BIOSCIENCE.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 BECKMAN COULTER, INC
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 BIOVISION INC. (ACQUIRED BY ABCAM PLC)
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 COMPANY SHARE ANALYSIS
16.11.4 PRODUCT PORTFOLIO
16.11.5 RECENT DEVELOPMENT
16.12 CELL GUIDANCE SYSTEMS LLC
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 CREATIVE BIOARRAY
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 CUSABIO TECHNOLOGY LLC
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 HBMLS (ACQUIRED BY LONZA)
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENT
16.17 HITACHI, LTD.
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 INOVIQ
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 JSR MICRO NV
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 MICROGENTAS
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 NANOSOMIX
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 NEXOSOME-ONCOLOGY
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
16.23 NORGEN BIOTEK CORP.
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 NOVUS BIOLOGICALS
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 PROTEOGENEX
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 QIAGEN
16.26.1 COMPANY SNAPSHOT
16.26.2 REVENUE ANALYSIS
16.26.3 PRODUCT PORTFOLIO
16.26.4 RECENT DEVELOPMENT
16.27 ROOSTERBIO, INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 PRODUCT PORTFOLIO
16.27.3 RECENT DEVELOPMENTS
16.28 SYSTEM BIOSCIENCES, LLC.
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, PRICING ANALYSIS
TABLE 2 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT , 2021-2030 (USD THOUSAND)
TABLE 3 NORTH AMERICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 NORTH AMERICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 5 NORTH AMERICA KITS AND REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 6 NORTH AMERICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 NORTH AMERICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 8 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 9 NORTH AMERICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 10 NORTH AMERICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 11 NORTH AMERICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 12 NORTH AMERICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 13 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 14 NORTH AMERICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 15 NORTH AMERICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 16 NORTH AMERICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 NORTH AMERICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 18 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 19 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 21 NORTH AMERICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 NORTH AMERICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 23 NORTH AMERICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 NORTH AMERICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 25 NORTH AMERICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 26 NORTH AMERICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 27 NORTH AMERICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 28 NORTH AMERICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 29 NORTH AMERICA OTHERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 30 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 31 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 32 NORTH AMERICA DIRECT SALES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 NORTH AMERICA ONLINE IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 34 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 35 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 36 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 37 NORTH AMERICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 38 NORTH AMERICA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 39 NORTH AMERICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 40 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 41 NORTH AMERICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 42 NORTH AMERICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 43 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 44 NORTH AMERICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 45 NORTH AMERICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 46 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 47 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 48 NORTH AMERICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 49 NORTH AMERICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 50 NORTH AMERICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 51 NORTH AMERICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 52 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 53 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 54 U.S. CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 55 U.S. KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 56 U.S. INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 57 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 58 U.S. CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 59 U.S. NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 60 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 61 U.S. THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 62 U.S. DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 63 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 64 U.S. PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 65 U.S. RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 66 U.S. ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 67 U.S. CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 68 U.S. HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 69 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 70 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 71 CANADA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 72 CANADA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 73 CANADA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 74 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 75 CANADA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 76 CANADA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 77 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 78 CANADA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 79 CANADA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 80 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 81 CANADA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 82 CANADA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 83 CANADA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 84 CANADA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 85 CANADA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 86 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 87 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 88 MEXICO CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 89 MEXICO KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 90 MEXICO INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 91 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 92 MEXICO CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 93 MEXICO NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 94 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 95 MEXICO THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 96 MEXICO DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 97 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 98 MEXICO PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 99 MEXICO RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 100 MEXICO ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 101 MEXICO CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 102 MEXICO HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 103 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
List of Figure
FIGURE 1 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN THE PREVALENCE OF CANCER AND OTHER AUTO-IMMUNE DISEASE IS EXPECTED TO DRIVE THE NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 12 THE CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET
FIGURE 14 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2022
FIGURE 15 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND)
FIGURE 16 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2022
FIGURE 19 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2023-2030 (USD THOUSAND)
FIGURE 20 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 22 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2022
FIGURE 23 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 24 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2022
FIGURE 27 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 28 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 32 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022)
FIGURE 35 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022)
FIGURE 36 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030)
FIGURE 39 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%)
